We previously reported that senescent human diploid fibroblasts (HDFs) are resistant to apoptosis induced by H 2 O 2 and staurosporine. We report here that senescent HDFs are resistant to thapsigargin-induced apoptosis as well. These agonists caused the reductions in mitochondrial membrane potential (MMP) and in the apoptosis inhibitory protein (B-cell lymphoma) only in young HDFs but not in senescent HDFs. In addition, downregulation of Bcl-2 increased the sensitivity of senescent HDFs to apoptosis induction, suggesting the significant role of Bcl-2 in apoptosis resistance of the senescent HDFs. We further found that P-cAMP response element-binding protein (CREB), a positive regulator of Bcl-2, decreased in stress-induced apoptosis of young HDFs but not in senescent HDFs, and that Bcl-2 was markedly reduced in CREB small interfering RNA (siRNA), transfected senescent HDFs. In addition, activity of protein phosphatase 2A (PP2A), which dephosphorylates p-CREB, significantly increased in young HDFs but not in senescent HDFs treated with H 2 O 2 , staurosporine or thapsigargin. Taken together, these results suggest that failure of stress-induced downregulation of Bcl-2 underlies resistance of senescent HDFs to apoptosis.
pathways. 13 We found that when treated with H 2 O 2 , staurosporine or thapsigargin, Bcl-2 is markedly downregulated in young HDFs but not in senescent HDFs. Also, stress-induced apoptosis was enhanced in senescent HDFs when the expression of Bcl-2 gene was repressed, using a small interfering RNA (siRNA). Both these results suggest that regulation of Bcl-2 plays an important role in mediating the resistance to a variety of apoptotic stimuli in senescent HDFs. In studies designed to elucidate the regulatory mechanism for Bcl-2 expression, we found that Bcl-2 was markedly reduced in cAMP response element-binding protein (CREB) siRNAtransfected senescent HDFs and that the activity of protein phosphatase 2A (PP2A) (which is involved in the regulation of the transcriptional activities of CREB, a positive regulator of Bcl-2 14 ) significantly increased in young HDFs treated with H 2 O 2 , staurosporine or thapsigargin but not in senescent HDFs. These findings confirm that downregulation of Bcl-2, which facilitates apoptosis in young HDFs, does not occur in senescent HDFs. This failure of downregulation of Bcl-2 in senescent cells is responsible for the resistance of these cells to stress-induced apoptosis.
Results
Senescent HDFs are resistant to thapsigargin-induced apoptosis. In a previous study, we reported that senescent HDFs showed apoptotic resistance toward H 2 O 2 and staurosporine in contrast to young HDFs. 1 Employing 3-(4,5-dimethylthiazal-z-yl)-2,5-diphenylterazolium (MTT) assays, we show here that senescent HDFs, unlike the young HDFs, resist thapsigargin-induced apoptosis as well. The increased survival of senescent HDFs, relative to young HDFs under thapsigargin-induced stress, is shown in Figure 1a . After thapsigargin treatment for 48 h, subG 1 /G 0 population significantly increased to 31.69% in young HDFs, whereas it did not change in senescent HDFs (Figure 1b and  c) . Also, caspase-3 and poly(ADP-ribose)polymerase (PARP) cleavage after thapsigargin treatment increased time dependently in young HDFs but not in the senescent HDFs (Figure 1d ).
Changes of mitochondrial membrane potential (DW m ) in young and senescent HDFs. Dissipation of mitochondrial membrane potential (DC m ) has been detected during the early stage of the apoptotic process, 15 and DC m has been reported to decrease in aged cell. [16] [17] [18] We therefore compared the changes of DC m in young and senescent HDFs in response to H 2 O 2 , staurosporine and thapsigargin treatments by analyzing DiOC 6 fluorescence by flow cytometry. As shown in Figure 2 , we observed that DC m of senescent HDFs decreased about two-fold compared with that of young HDFs, but dissipation of DC m was significantly increased in young HDFs but not in the senescent HDFs undergoing H 2 O 2 , staurosporine or thapsigargin-induced apoptosis.
Failure of stress-induced downregulation of Bcl-2 in senescent HDFs. The early events of apoptosis, including the reduction in DC m , are regulated by proapoptotic proteins such as Bax 19 and antiapoptotic proteins such as Bcl-2 and Bcl-x L . 20 The ratio of Bcl-2 to Bax following an apoptotic stimulus is believed to mainly determine whether a cell survives or dies. 21 We monitored the expression levels of Bcl-2 family proteins in young and senescent HDFs before and after treatments with H 2 O 2 , staurosporine and thapsigargin. We observed that the basal expression levels of proapoptotic Bcl-2 family proteins such as Bak, Bik, Bok and Puma decreased in the senescent HDFs compared with young HDFs, whereas other Bcl-2 family proteins such as Bax and Bcl-x L did not change (Supplementary Figure 1) . The expression of Bcl-2 significantly increased in the senescent HDFs to 2.5-fold that of young HDFs (Figure 3a and b) . Moreover, when HDF cells were treated with apoptotic stimuli (H 2 O 2 , staurosporine or thapsigargin), only young HDFs showed a reduction of Bcl-2 expression in contrast to senescent HDFs, which showed little or no change in the expression of Bcl-2 ( Figure 3c ). When we performed RT-PCR using specific Bcl-2 primer, Bcl-2 mRNA levels were downregulated in stress-induced apoptosis of young HDFs but not in senescent HDFs (Figure 3d ), suggesting that the reduction of Bcl-2 occurs at the transcription level.
Role of Bcl-2 in apoptotic resistance of senescent HDFs. We downregulated Bcl-2 expression in senescent HDFs employing three different Bcl-2 siRNAs (no. 1, 2, and 3). A marked reduction of Bcl-2 protein as well as mRNA levels was evident 72 h after transfection of Bcl-2-specific siRNAs in senescent HDFs, compared to transfection of a control siRNA that had no effect (Figure 4a, b and c) . When we downregulated Bcl-2 in senescent HDFs by transfecting with Bcl-2 siRNA no. 3, and examined their survival rates following treatment with 1.5 mM H 2 O 2 , 100 nM staurosporine or 100 nM thapsigargin for 24, 16 and 48 h, respectively, their survival rates were reduced after all the three treatments (Figure 4g ). In a previous study, we found that caspase-3 and PARP cleavages did not occur in H 2 O 2 -induced apoptosis of both young and senescent HDFs. 1 Dysregulation of phospho-CREB in the senescent HDFs. CREB, a Bcl-2 transcription factor, plays a critical role in regulation of apoptosis in many cell types. 22, 23 Phosphorylation of CREB on Ser-133 is associated with its increased transcriptional activity. 24 To investigate whether an increase in Bcl-2 level ( Figure 3 ) correlates with phosphorylation of CREB, we checked phosphorylation status of CREB in H 2 O 2 , staurosporine or thapsigargintreated young and senescent HDFs. As shown in Figure 5a , p-CREB (Ser-133) decreased in stress-induced apoptosis of young HDFs, in a time-dependent manner. Moreover, we found that young HDFs were more sensitive to the downregulation of p-CREB in staurosporine or H 2 O 2 -induced apoptosis compared with thapsigargin-induced apoptosis. However, p-CREB did not change in senescent HDFs after apoptotic stress (Figure 5b ). In addition, we observed that the activity of other Bcl-2 transcription factors such as nuclear factor kappa B (NF-kB) and p53 did not change significantly in H 2 O 2 , staurosporine or thapsigargintreated young and senescent HDFs (data not shown). To investigate whether CREB directly influences Bcl-2 levels, we reduced CREB levels in senescent HDFs using specific CREB-siRNA. As shown in Figures 5c and d, Bcl-2 was markedly reduced by the downregulation of CREB in CREB siRNA-transfected senescent HDFs but not in control siRNAtransfected senescent HDFs.
Protein phosphatase 2A (PP2A) is the primary enzyme that leads to dephosphorylation of p-CREB. 14 To investigate whether PP2A is involved in dephosphorylation of p-CREB in stress-induced apoptosis of young and senescent HDFs, we determined PP2A activities in young and senescent HDFs before and after agent treatments with H 2 O 2 , staurosporine and thapsigargin. As shown in Figure 6 , apoptotic stimuli significantly increased PP2A activities only in young HDFs but not in senescent HDFs.
Discussion
Apoptosis plays an important role in many physiological and pathological processes, including aging and age-related diseases. One remarkable characteristic of the senescent phenotype is apoptotic resistance. How senescence develops apoptotic resistance is not clear. We focused on the role of Bcl-2 family proteins and their regulation for the resistance to apoptosis in senescent cells. A drop in mitochondrial membrane potential (DC m ) has been observed during early apoptosis induced by various apoptotic stimuli in many cell types. 25, 26 It has been reported that some of the Bcl-2 family proteins, such as Bcl-2, Bcl-x L and Bax, might directly modulate the DC m 19,20 and the ratio of Bcl-2 to Bax determines whether a cell survives or dies following an apoptotic stimulus. 21 In this study, DC m did not change in senescent HDFs subjected to the apoptotic stress, whereas it was significantly reduced in young HDFs (Figure 2 ). In addition, we found that Bcl-x L and Bax did not change in both young and senescent HDFs, but Bak, Bok, Bik and Puma decreased in senescent HDFs but not in young HDFs in contrast. (Supplementary Figure 1) . Although several studies suggest that DC m is reduced in aged hepatocytes, fibroblasts, lymphocytes and cardiomyocytes, [16] [17] [18] the underlying molecular mechanism is not clear. Whether a decrease in Bak, Bok, Bik and Puma levels confers the decrease of DC m in senescent HDFs requires further study.
Since its discovery in the mid-1980s, proto-oncogene Bcl-2 has been shown to be a central player in mammalian cell death pathways. 8 Bcl-2 levels are reported to be high in follicular lymphoma, melanoma, and prostates and glioma cancer cells. 27, 28 We observed that Bcl-2 expression increased about 2.5-fold in senescent HDFs compared with young HDFs (Figure 3a and b) . There have been several reports that apoptosis owing to external toxic stimuli can be rescued by Bcl-2. 29, 30 As shown in Figures 3c and d , Bcl-2 protein and mRNA levels were downregulated by H 2 O 2 , staurosporine or thapsigargin treatments in the young HDFs but not in the senescent HDFs. Based on these findings, we hypothesized that the decrease in Bcl-2 sensitizes senescent HDFs to apoptotic stimuli and, conversely, increased levels of Bcl-2 in senescent cells makes them resist apoptotic stimuli. We confirmed this hypothesis by showing that downregulation of Bcl-2 in senescent HDFs, employing specific siRNA, resulted in the increased apoptotic sensitivity to stimuli such as H 2 O 2 , staurosporine and thapsigargin (Figure 4) .
To understand why senescent HDFs contain higher levels of Bcl-2, we compared the levels of transcriptional factors for Bcl-2 genes in young and senescent HDFs, because a wide range of transcription factors, including CREB, Sp1, NF-kB, Myb and p53, have been shown to be involved in the regulation of Bcl-2 in different cell types. [31] [32] [33] [34] As shown in Figure 5 , p-CREB (Ser-133), which upregulates the transcription of Bcl-2, decreased after apoptotic stimuli in young HDFs but not in the senescent HDFs. There were no significant differences in the levels of other transcription factors for Bcl-2, such as NF-kB, Sp1 and p53, between the young and senescent HDFs subjected to the apoptotic stress (data not shown). Therefore, we focused on the regulatory role of p-CREB in age-related changes in Bcl-2. Downregulation of CREB by a specific siRNA caused the reduction in Bcl-2 (Figure 5c ), which indicates an essential role of CREB for Bcl-2 expression. In addition, as the phosphorylation status of p-CREB on Ser-133 regulates the expression of Bcl-2, we compared PP2A activity in young and senescent HDFs after apoptotic stress. This enzyme is involved in inactivating CREB transcriptional activity by dephosphorylation of p-CREB. 15, 16 Several recent studies have reported that activity of PP2A can be enhanced by the proapoptotic lipid ceramide and etoposide. 35 However, we found that PP2A activities significantly increased in young HDFs but not in the senescent HDFs after apoptotic stimuli ( Figure 6 ). This indicates that increased activity of PP2A may possibly downregulate the Bcl-2 gene via dephosphorylation of p-CREB (Ser-133) only in the young HDFs. The reasons for these age-dependent changes in PP2A are not clear. It has recently been reported that PP2A activity is regulated by methylation of catalytic subunit and oxidation of cysteine residues in PP2A in the senescent HDFs. 35, 36 Moreover, agedependent increase of caveolin might suppress PP2A activity by their interaction. 37 Which of these mechanisms are operating dominantly in the senescent cells remains to be clarified.
In summary, senescent HDFs in contrast with young HDFs resist apoptosis, induced by three distinct stimuli: H 2 O 2 , Figure 4 Role of Bcl-2 in apoptotic resistance in senescent HDFs. Senescent HDFs were transfected with three different siRNAs of Bcl-2 and control siRNA of GL2 luciferase, an siRNA directed against the firefly luciferase, using Oligofectamine. After 72 h, cells were harvested. Protein and mRNA expression of Bcl-2 were analyzed by Western blotting using anti-Bcl-2 antibody (a) and RT-PCR using Bcl-2 primer (c). 
Materials and Methods
Reagents. HDFs were isolated from human foreskins. Monoclonal antibody against actin (A5441) was purchased from Santa Cruz Biotechnology Inc. Polyclonal antibodies against PARP (9542), Caspase-3 (9662), Bcl-2 (2872), and p-CREB (9198) were purchased from Cell Signaling Technologies Inc. Staurosporine (569397) was from Calbiochem (La Jolla, CA, USA). Hydrogen peroxide (216763), thapsigargin (T9033), propidium iodide, and MTT were from Sigma Chemical Co (St. Louis, MO, USA). DiOC 6 (3, 3 0 -diethyloxacarbocyanine) was from Molecular Probes. Ser/Thr Phosphatase Assay Kit 1 (17-127) was from Upstate Biotechnology Inc. Secondary horseradish peroxidase-conjugated antirabbit and antimouse antibodies were purchased from Zymed Laboratories Inc., and chemiluminescent detection systems were purchased from Pierce. All other biochemical reagents were from Sigma or Invitrogen.
Cell culture and treatment. The primary culture of normal HDF was isolated from the foreskin of a 4-year-old boy. HDFs were kept in 100 mm tissue culture dishes in Dulbecco's modified Eagle's medium, supplemented with 10% fetal bovine serum (FBS), 100 m/ml penicillin, and 100 mg/ml streptomycin, maintained in 5% CO 2 in a humid incubator at 371C. Cells were split serially in vitro. Young HDFs were frozen until old HDFs were generated through increased passages. Young proliferating cells and old near-senescent cells were collected at the doubling time of 24 h and over 2 weeks, respectively. Cellular senescence was confirmed using a senescence-associated (SA) b-galactosidase activity assay. HDFs were grown to 70% confluence and then treated with 1.5 mM H 2 O 2 , 100 nM staurosporine or 200 nM thapsigargin in serum-free media for the times indicated in Results.
Measurement of mitochondrial membrane potential (DW m ).
Measurement of mitochondrial membrane potential was performed as described previously. 38 Briefly, HDFs were plated at a density of 3 Â 10 5 (young cells) or 5 Â 10 4 (senescent cells) on 100 mm culture plates. After treatment with H 2 O 2 , staurosporine and thapsigargin, respectively, for the times indicated in results, the cells were harvested by trypsinization, washed with culture medium and incubated with 80 nM DiOC 6 (3,3 0 -diethyloxacarbocyanine; Molecular probes) for 30 min in Analysis of apoptosis by cell cycle. Before treatment with H 2 O 2 , staurosporine and thapsigargin, cells were seeded in a 100 mm dish at 3 Â 10 5 cells per dish. After treatments, the cells were harvested using trypsin-ethylenediamine-N,N,N 0 ,N 0 -tetraacetic acid (EDTA), combined with floating cells collected from the medium, washed twice with PBS and fixed with ice-cold 70% ethanol. Cells were centrifuged and the ethanol supernatants discarded. The pelleted cells were then stained with 50 mg/ml propidium iodide (PI) plus RNase A for 20 min, and analyzed for DNA content on a FACScan flow cytometer (Becton Dickinson FACSorter) using CELLQuest software. Error bars represent standard deviations of the means.
Immunoblot analysis. Cells were lysed with lysis buffer containing 50 mM Tris pH 7.4, 150 mM NaCl, 1 mM EDTA pH 8.0, 1 mM protease inhibitor cocktail (Roche), 1 mM phenylmethylsulphonyl fluoride (PMSF), 1 mM NaF and 1 mM sodium orthovanadate. Protein contents were determined using Bradford assay. 40 mg protein of each sample was resolved by SDS-PAGE, transferred onto nitrocellulose membranes (Schleicher & Schuell Bioscience Inc) and blocked with TBS containing Tween-20 in 2.5% nonfat dry milk. The membranes were incubated with the primary antibodies at 41C for 16 h. Secondary antibodies were added for 1 h at RT. The antibody-antigen complexes were detected using the ECL detection system (Pierce).
Semiquantitative RT-PCR. Total RNA was extracted from cultured HDFs using TRIZOL reagent (invitrogen), according to the manufacturer's protocol. Extracted RNA was treated with DNase I (Roche Diagnostics, Mannheim, Germany) and reverse transcribed to single-stranded cDNAs using oligo(dT) 12-18 primer with Superscript II reverse transcriptase (invitrogen). Appropriate dilutions of each single-stranded cDNA were prepared for subsequent PCR amplification by monitoring the actin gene as a quantitative control. Primer sequences were as follows: 5 0 -GGT GCC ACC TGT GGT CCA CCT G-3 0 and 5 0 -CTT CAC TTG TGG CCC AGA TAG G-3 0 for Bcl-2. 5 0 -CTG TGT GGA CTT GGG AGA GG-3 0 and 5 0 -GGC ATC CAC GAA ACT ACC TT-3 0 for GAPDH. RT-PCR was performed using the following conditions for Bcl-2 gene: 421C for 1 h, 951C for 15 min, 32 cycles of (i) 941C for 30 s, (ii) 621C for 30 min, (iii) 721C for 1 min and 721C for 10 min. Samples were analyzed by gel electrophoresis and bands were revealed by staining gels with ethidium bromide.
Protein phosphatase 2A activity assay. To determine the activity of PP2A, cells were washed twice with phosphate-free medium and lysed with a phosphatase extraction buffer containing 20 mM imidazole-HCl, 2 mM EGTA, 2 mM EDTA, pH 7.0, with protease inhibitor cocktail (Roche, 1 697 498), 1 mM PMSF, by sonication (Sonic Dismembrator 550, Fisher) twice at level 2 for 5 s. The whole Immunoblot analyses were performed using CREB, p-CREB (Ser-133) and Bcl-2-specific antibodies. The blots were reprobed with antibody against actin to confirm equal protein loading. STP, staurosporine; THAP, thapsigargin lysates were centrifuged at 11 000 Â g for 10 min, and the supernatants were used for the enzyme assay. Malachite Green Assay kit (Upstate Biotechnology, Lake Placid, NY, USA) was mixed with Thr(P) peptide (KRpTIRR, catalog number 12-219) purchased from Upstate Biotechnology Inc., as a substrate. An assay mixture (25 ml) containing 250 mM of substrate and 2 mg of each supernatant were incubated at 301C for 10 min and then 100 ml of malachite green phosphate detection solution was. For color development, the assay mixture was incubated for 15 min at room temperature. To eliminate phosphate contamination arising from the cell extracts and the reagents, an assay mixture without the substrate or reagent was run. Phosphate released by the enzyme reaction was determined from the standard curve prepared with 0.1 mM potassium phosphate monobasic, KH 2 PO 4 . Absorbance of each well at 630 nm was read using a microplate reader (Benchmark, Bio-Rad).
RNA Interference and transfection. We targeted three regions of Bcl-2 mRNA and two regions of CREB mRNA for RNA interference. The target sequences were as follows: Bcl-2 #1: 5 0 -GGGAGGATTGTGGCCTTCTTTGAGT-3 0 ; Bcl-2 #2: 5 0 -ACATCGCCCTGTGGATGACTGAGTA-3 0 ; Bcl-2 #3: 5 0 -ACCTG CACACCTGGATCCAGGATAA-3 0 ; CREB: 5 0 -ACAGCTGGCTAACAATGG-3 0 . A synthetic siRNA directed against the firefly luciferase mRNA sequence 5 0 -AACGUACGCGGAAUACUUCGA-3 0 was used as a negative control. The siRNAs were purchased from Dharmacon Research (Lafayette, CO, USA) as duplexed 2'unprotected desalted and purified siRNAs. The transfection of siRNA duplexes was performed as described previously. 39 Briefly, senescent HDFs (5 Â 10 4 ) were plated in a 100 mm dish, transfected with 0.5 nmole of siRNA and Oligofectaminet reagent in serum-free medium and incubated for 4 h at 371C in a CO 2 incubator. Following incubation, the cells were supplied with growth medium containing 10% fetal bovine seerum. Figure 6 PP2A activity in H 2 O 2 , staurosporine or thapsigargin-treated young and senescent HDFs. Following 1.5 mM H 2 O 2 , 100 nM staurosporine or 100 nM thapsigargin-treated young and senescent HDFs for indicated times, the PP2A activity was assayed, as described in Materials and Methods. The results shown are representative of three independent experiments; the histograms represent average and error bars represent standard deviations of the means. Significance was tested by ANOVA followed by a Dunnett post-test to compare the drug-treated group at each time point versus the control group. A double asterisk (**) denotes Po0.01
